The Big Catch-Up has achieved much of what it set out to do. Its legacy could last generations

The key market implication is not a direct equity beta story but a multi-year shift in how frontier and emerging-market health systems are financed and executed. A successful catch-up campaign tends to pull forward procurement of pediatric vaccines, cold-chain equipment, last-mile logistics, and digital registry tools, then converts those into recurring spend once ministries embed catch-up into routine protocols. That makes the durable beneficiaries the “picks and shovels” layer—global health logistics, vaccine suppliers with public-sector exposure, and local distributors with existing Ministry of Health relationships—rather than any single headline beneficiary.

The second-order effect is improved system throughput: when zero-dose populations are reached, governments usually discover adjacent unmet demand for antenatal care, nutrition, basic diagnostics, and chronic disease screening. That can lift utilization at low-margin primary-care providers and create incremental funding flows from multilaterals, but it also raises expectations for follow-through, which is where execution risk sits. If fiscal pressures widen or donor budgets reallocate toward higher-priority geopolitical areas, the catch-up momentum could fade after the first implementation wave, especially where the easy-to-reach cohorts were already harvested.

The contrarian point is that the market may be overestimating how linear the benefit curve is. The biggest gains have likely already come from the most addressable cohorts; the remaining children are the most expensive to reach and are disproportionately exposed to conflict, urban hesitation, or weak administrative capacity. That means the next leg is slower and more politically fragile, so any optimism around sustained vaccine-volume growth should be tempered by the risk that coverage plateaus even as headline programs continue, leaving vendors with lumpy order patterns rather than a smooth step-up in demand.